Representatives of the largest Polish companies Polpharma Group and Adamed also took part in the meeting.

At the negotiations, the possibilities of implementing an investment project for the production of pharmaceutical products in Uzbekistan were discussed.

The Polish side highly appreciated the favorable conditions created for foreign investors in our country, including for companies producing pharmaceutical products. Krzysztof Kopeć expressed interest in participating in the creation of the innovative research and production pharmaceutical cluster “Tashkent Pharma Park”.

Following the meeting, an agreement was reached to organize a study visit of the delegation of the Polish Association of the Pharmaceutical Industry to Uzbekistan.